TMF AUDITS SERVICES
BioBoston CRO provides Trial Master File audit services for sponsors and clinical organizations that need an independent assessment of TMF or electronic TMF completeness, quality, timeliness, traceability, governance, and inspection readiness. Support can cover an in-study risk-based review, milestone audit, end-of-study audit, vendor oversight audit, remediation assessment, or focused inspection-readiness review.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
The engagement should be scoped around the current state of the work, the intended decision or milestone, the source package, and the sponsor's approval responsibilities.
Sample critical sections, milestones, countries, sites, vendors, and document lifecycles before deficiencies accumulate through closeout.
Assess completeness, quality, timeliness, metadata, reconciliation, access, retrieval, and unresolved gaps against the expected trial story.
Evaluate governance, responsibilities, filing quality, metrics, overdue items, quality reviews, issue handling, transfers, and sponsor access evidence.
when needed
Problems
The service is most valuable when the team can identify the specific control gap, decision, deliverable, or
recovery need rather than requesting generic capacity.
Scope
The exact scope depends on the maturity of the work, the quality of the inputs, the sponsor’s procedures,
the review model, and the target milestone.
Deliverables
Deliverables should be confirmed at kickoff and linked to defined sponsor decisions, review cycles, and downstream handoffs.
Client inputs
The sponsor does not need every detail finalized before kickoff, but approved decisions, open questions, source owners, reviewers, and deadlines must be distinguishable.
Process
1. Confirm the purpose, current state, intended use, milestone, stakeholders, responsibilities, systems or vendors, and agreed deliverables.
2. Review available source materials, prior decisions, procedures, evidence, and open issues; issue a focused gap and dependency list.
3. Develop the work plan, specifications, document, assessment, or control package included in scope.
4. Coordinate review through named sponsor and cross-functional decision owners and maintain a controlled open-item and comment process.
5. Perform the agreed technical, quality, consistency, or operational checks and document remaining risks or limitations.
6. Prepare the approved handoff, implementation, submission, remediation, archive, or next-step package as defined in scope.
Considerations
The work should remain proportionate to the risk and intended use, follow the sponsor’s controlled process, and preserve clear sponsor decision authority.
Engagement options
BioBoston leads the defined scope from assessment and planning through drafting or execution, review, quality control, and handoff.
BioBoston addresses a specific section, decision, backlog, finding, vendor issue, or stalled deliverable without expanding the engagement unnecessarily.
BioBoston provides an objective second-line review, oversight role, or embedded specialist while the sponsor or another vendor retains primary execution.
RELATED SERVICES
Assess broader study, site, vendor, process, system, and sponsor controls beyond the TMF
Test real-time retrieval, document-room control, interviews, responses, and inspection governance using TMF evidence.
Strengthen sponsor control over a CRO-managed TMF, quality reviews, metrics, issues, transfers, and closeout.
Investigate systemic TMF findings and develop remediation, implementation evidence, and effectiveness checks.
Expertise
TMF-auditor experience should match the study phase, product, TMF model, electronic system, sponsor
and vendor responsibilities, geography, document volume, and inspection or closeout context.
RESOURCES
Explore the following resources for additional insights and information relevant to this service.
A planned checklist for plan, index, expected documents, lifecycle, metadata, quality, timeliness, governance, reconciliation, retrieval, and archive.
A planned framework for critical processes, sections, milestones, countries, sites, vendors, document types, and quality signals.
A planned tool for gap, evidence, risk, root cause, action, owner, deadline, document status, verification, and closure.
FAQs
A TMF audit may assess planning, expected documents, completeness, timeliness, content quality,
metadata, version and approval status, traceability, filing, reconciliation, governance, system controls, retrieval, transfer, closeout, and archive readiness.
Yes, when system access, sponsor and CRO responsibilities, TMF plan, metrics, quality reviews, records, governance evidence, and confidentiality arrangements are available.
A health check may be a narrower operational or quality review. An audit is an independent assessment against defined criteria with formal scope, evidence, findings, reporting, and follow-up expectations.
Yes. Scope should reflect closeout status, expected documents, unresolved sites and vendors, reconciliations, final approvals, transfers, retrieval, and archive requirements.
Yes. Remediation may include gap triage, document recovery, quality correction, metadata and filing correction, reconciliation, root-cause analysis, process changes, oversight, and verification.
No. It provides a risk-based independent assessment using defined sampling and available evidence, but it
cannot guarantee that every gap is identified or predict authority conclusions.
PROJECT FORM
Share the study, TMF or eTMF model, current stage, sponsor and vendor responsibilities, known metrics or gaps, target milestone, and desired audit timing. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the study stage, TMF model, system, expected documents, responsibilities, metrics, prior findings, access, and target milestone. BioBoston can then define the audit sample, methodology, reporting, and follow-up scope.
